Baxter International, Inc. (BAX)
| Market Cap | 26.83B |
| Revenue (ttm) | 14.74B |
| Net Income (ttm) | -2.38B |
| Shares Out | 504.00M |
| EPS (ttm) | 2.00 |
| PE Ratio | 25.65 |
| Forward PE | 14.43 |
| Dividend | $1.15 (2.24%) |
| Ex-Dividend Date | Dec 1, 2022 |
| Volume | 4,940,515 |
| Open | 52.78 |
| Previous Close | 53.22 |
| Day's Range | 51.13 - 52.98 |
| 52-Week Range | 49.83 - 89.7 |
| Beta | 0.59 |
| Analysts | Buy |
| Price Target | 65.01 (+26.7%) |
| Earnings Date | Oct 27, 2022 |
About BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical pro... [Read more]
Financial Performance
In 2021, BAX's revenue was $12.78 billion, an increase of 9.52% compared to the previous year's $11.67 billion. Earnings were $1.28 billion, an increase of 16.52%.
Financial StatementsAnalyst Forecast
According to 21 analysts, the average rating for BAX stock is "Buy." The 12-month stock price forecast is 65.01, which is an increase of 26.73% from the latest price.
News
Baxter Introduces ExactaMix Pro, Next-Generation Automated Nutrition Compounder, at ASHP Meeting
DEERFIELD, Ill.--( BUSINESS WIRE )--Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, announces the launch of the ExactaMix Pro Automated Compounder, which is expected to be av...
Baxter to Present at the 5th Annual Evercore ISI HealthCONx Conference
DEERFIELD, Ill.--( BUSINESS WIRE )--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022. Jay Sa...
Baxter Declares Quarterly Dividend
DEERFIELD, Ill.--( BUSINESS WIRE )--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share o...
Baxter Highlights New Home Dialysis and HDx Therapy Data in 14 Clinical Presentations at Kidney Week 2022
DEERFIELD, Ill., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, advanced scientific exchange with 14 new data presentations about the role inn...
Spectral Medical Inc. Closes $10.8 Million Public Offering and Concurrent Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Baxter (BAX) Q3 Earnings Meet Estimates, Hilrom Adds $735 M
Baxter's (BAX) third-quarter results reflect the robust performance of the Medication Delivery business unit and Hilrom's businesses.
Baxter International (BAX) Q3 Earnings Match Estimates
Baxter (BAX) delivered earnings and revenue surprises of 0% and 0.03%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Block, RingCentral, and Other Stocks Facing Tax-Loss Selling
Some of the stocks that have suffered the most this year could get hit some more as investors sell them to create tax losses.
Baxter (BAX) to Report Q3 Earnings: Is a Beat in the Cards?
Baxter's (BAX) third-quarter results are likely to reflect growth in its Medication Delivery and Advanced Surgery businesses. Hillrom's products are likely to have boosted sales.
Analysts Estimate Baxter International (BAX) to Report a Decline in Earnings: What to Look Out for
Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Reasons to Retain Baxter (BAX) Stock in Your Portfolio
Investors remain optimistic about Baxter (BAX) due to its strong product portfolio.
The Baxter International Foundation Announces $3 Million in New Grants to Organizations Working to Advance Racial Jus...
DEERFIELD, Ill.--(BUSINESS WIRE)--The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), announced today it will provide a combined $3 million in new racial ...
Should You Buy Baxter Stock Under $60?
Baxter stock (NYSE: BAX) has seen a 32% fall this year, underperforming the broader S&P500 index, down 17%.
Baxter to Host Third-Quarter 2022 Financial Results Conference Call for Investors
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2022 financial results on Thursday, October 27, ...
Baxter Expands Historically Black Colleges and Universities Partnerships, Funding Commitments to Further the Pipeline...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reinforced its commitment to expand the pipeline of Black healthcare professionals through several ...
Baxter (BAX) Novum IQ SYR's FDA Clearance Boosts Patient Care
Latest regulatory approval for Baxter's (BAX) Novum IQ SYR is expected to provide safe and accurate infusions for vulnerable patients.
Two-Minute Drill: FedEx, Verizon & Baxter
Burns McKinney, NFJ Investment, joins ‘Closing Bell: Overtime' to give his take on FedEx, Verizon and Baxter.
Baxter Announces U.S. FDA Clearance of Novum IQ Syringe Infusion Pump with Dose IQ Safety Software
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced U.S. Food and Drug Administration (FDA) 510(k) clearanc...
Baxter to Present at the 2022 Wells Fargo Healthcare Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022. Jay Saccaro, ...
Baxter to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14, 2...
Baxter (BAX) Q2 Earnings Miss Estimates, Hilrom Adds $715 M
Baxter's (BAX) second-quarter results reflect the robust performance of the Medication Delivery business unit and Hilrom's businesses.
Why Baxter International Stock Is Tumbling Today
Investors weren't happy with the company's Q2 update.
Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates
Baxter (BAX) delivered earnings and revenue surprises of -1.14% and 3.73%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?